PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO (English)
- New search for: Vargas-Valencia, J. J.
- New search for: Sotelo-Guzmá
- New search for: n, M.
- New search for: Dí
- New search for: az-Ponce, H.
- New search for: Galindo-Suá
- New search for: rez, R. M.
- New search for: Muciñ
- New search for: o-Ortega, E.
- New search for: Mould-Quevedo, J. F.
- New search for: Vargas-Valencia, J. J.
- New search for: Sotelo-Guzmá
- New search for: n, M.
- New search for: Dí
- New search for: az-Ponce, H.
- New search for: Galindo-Suá
- New search for: rez, R. M.
- New search for: Muciñ
- New search for: o-Ortega, E.
- New search for: Mould-Quevedo, J. F.
In:
VALUE IN HEALTH
;
14
, 7
;
A559
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO
-
Contributors:Vargas-Valencia, J. J. ( author ) / Sotelo-Guzmá ( author ) / n, M. ( author ) / Dí ( author ) / az-Ponce, H. ( author ) / Galindo-Suá ( author ) / rez, R. M. ( author ) / Muciñ ( author ) / o-Ortega, E. ( author ) / Mould-Quevedo, J. F. ( author )
-
Published in:VALUE IN HEALTH ; 14, 7 ; A559
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2011-01-01
-
Size:A559
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 14, Issue 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. et al. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. et al. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. et al. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. et al. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. et al. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. et al. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. et al. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. et al. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. et al. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. et al. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. et al. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. et al. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. et al. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. et al. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. et al. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. et al. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. et al. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. et al. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. et al. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. et al. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. et al. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. et al. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. et al. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. et al. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. et al. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. et al. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. et al. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. et al. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. et al. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. et al. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. et al. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. et al. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. et al. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. et al. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. et al. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. et al. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. et al. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. et al. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. et al. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. et al. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. et al. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. et al. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. et al. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. et al. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. et al. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. et al. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. et al. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. et al. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. et al. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. et al. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. et al. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. et al. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. et al. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. et al. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. et al. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. et al. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. et al. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. et al. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. et al. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. et al. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. et al. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. et al. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. et al. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. et al. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. et al. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. et al. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. et al. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. et al. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. et al. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. et al. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. et al. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. et al. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. et al. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. et al. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. et al. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. et al. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. et al. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. et al. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. et al. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. et al. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. et al. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. et al. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. et al. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. et al. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. et al. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. et al. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. et al. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. et al. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. et al. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. et al. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. et al. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. et al. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. et al. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. et al. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. et al. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. et al. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. et al. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. et al. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. et al. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. et al. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. et al. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. et al. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. et al. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. et al. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. et al. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. et al. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. et al. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. et al. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. et al. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. et al. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. et al. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. et al. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. et al. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. et al. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. et al. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. et al. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. et al. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. et al. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. et al. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. et al. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. et al. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. et al. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. et al. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. et al. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. et al. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. et al. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. et al. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. et al. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. et al. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. et al. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. et al. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. et al. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. et al. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. et al. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. et al. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. et al. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. et al. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. et al. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. et al. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. et al. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. et al. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. et al. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. et al. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. et al. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. et al. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. et al. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. et al. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. et al. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. et al. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. et al. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. et al. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. et al. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. et al. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. et al. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. et al. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. et al. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. et al. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. et al. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. et al. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. et al. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. et al. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. et al. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. et al. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. et al. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. et al. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. et al. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. et al. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. et al. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. et al. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. et al. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. et al. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. et al. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. et al. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. et al. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. et al. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. et al. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. et al. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. et al. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. et al. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. et al. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. et al. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. et al. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. et al. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. et al. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. et al. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. et al. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. et al. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. et al. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. et al. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. et al. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. et al. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. et al. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. et al. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. et al. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. et al. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. et al. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. et al. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. et al. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. et al. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. et al. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. et al. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. et al. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. et al. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. et al. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. et al. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. et al. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. et al. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. et al. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. et al. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. et al. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. et al. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. et al. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. et al. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. et al. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. et al. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. et al. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. et al. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. et al. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. et al. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. et al. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. et al. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. et al. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. et al. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. et al. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. et al. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. et al. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. et al. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. et al. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. et al. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. et al. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. et al. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. et al. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. et al. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. et al. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. et al. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. et al. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. et al. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. et al. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. et al. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. et al. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. et al. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. et al. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. et al. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PRM7 Using Probabalistic Sensitivity Analysis in Budget Impact Models to Reduce Uncertainty and Improve Decision-MakingLatif, F. / Roberts, G. et al. | 2011
-
PRM32 Feasibility and Validity of the TiC-PBouwmans, C. / De Jong, K. / Timman, R. / Hakkaart-Van Roijen, L. et al. | 2011
-
PRM61 Sample Size Estimation for Prospective Observational StudiesCox, T. A. / Gemmen, E. / Nixon, M. / Doyle, J. / Burgess, A. J. / Jo, H. / Kamble, S. et al. | 2011
-
PCN1 Burden of Hospitalization in Patients with Advanced Lung Cancer in France and GermanyLobosco, S. / Taylor-Stokes, G. / Iyer, S. et al. | 2011
-
PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric CancerOh, J. Y. / Lee, E. K. et al. | 2011
-
PCN118 Consumption of Antineoplastic Agents in Slovak Republic Within Period of 2006-2010Gatialova, K. / Bellova, K. / Binder, R. / Foltan, V. / Snopkova, M. et al. | 2011
-
PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast CancerSkoupá / J. / Orlewska, E. / Kalo, Z. / Há / jek, P. et al. | 2011
-
PCN149 Health State Utility Values in Breast Cancer: A Review and Meta-AnalysisPeasgood, T. / Ward, S. E. / Brazier, J. et al. | 2011
-
PCN167 National Formulary Review of the Drugs Used in Pancreatic Neuroendocrine Tumors in KoreaLee, Y. S. / Park, E. J. et al. | 2011
-
PCN181 The Health Related Quality of Life Data (HRQoL) for Health Technology Assessment (HTA) Process in Europe: Their Utilization and Impact on Opinions across HTA AgenciesStamenkovic, S. et al. | 2011
-
PCN182 What Kind of Changes Did the Publication of Two Large-Scale RCTs Lead to in Prostate Cancer Screening Guidelines?Hamashima, C. et al. | 2011
-
PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer StudiesGilet, H. / Bré / dart, A. / Regnault, A. / Bhandary, D. / Parasuraman, B. et al. | 2011
-
PDB21 Natural History of Beta Cell Rate of Decline and Its Effect on Development of Secondary Complications in Type 1 DiabetesRodriguez, R. D. / Sarsour, K. / Mitchell, B. / Bowman, L. et al. | 2011
-
PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov ModelAdarkwah, C. C. / Evers, S. / Akkerman, M. / Gandjour, A. et al. | 2011
-
PDB62 The Impact of Clinical Inertia in the Treatment of Type 2 DiabetesMcEwan, P. / Prettyjohns, M. / Ketsetzis, G. / Evans, L. M. / Bergenheim, K. et al. | 2011
-
PDB67 Treatment Patterns and Health Outcomes Among Type 2 Diabetes with Comorbid Obesity in France, Germany, And UKDiBonaventura, M. D. / Isherwood, G. / Le Pautremat, V. / Eschwè / ge, E. et al. | 2011
-
PRS29 Evaluation of Stable COPD Medication Costs in Ukraine Based on GPS' Prescriptions Habits Survey ResultsHolovatyuk, I. / Zalis' / ka, O. / Tolubaiev, V. et al. | 2011
-
PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in GreeceAthanasakis, K. / Igoumenidis, M. / Karampli, E. / Vitsou, E. / Kyriopoulos, J. et al. | 2011
-
PRS50 The Dutch 1-Year Resource Use Results from the Experience Study, an International Registry of Real-World Outcomes for Asthma Patients Treated with Omalizumabvan Nooten, F. / Thompson, C. / Brown, R. / Groot, M. et al. | 2011
-
PRS69 Socioeconomic Determinants of Smoking Status in GreeceAthanasakis, K. / Zavras, D. / Pavi, E. / Kyriopoulos, J. et al. | 2011
-
PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian CohortPetrella, R. J. / Blouin, J. / Davies, B. / Barbeau, M. et al. | 2011
-
PSS21 Treatment Patterns, Costs and Quality of Life in Patients With Plaque Psoriasis in DenmarkRagnarson tennvall, G. / Hjortsberg, C. / Gniadecki, R. / Jemec, G. B. / Kragballe, K. / Miller, I. M. et al. | 2011
-
PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Comparative Results From 5 European CountriesIskedjian, M. / Berbari, J. / Navarro, V. / Farah, B. / Detzel, P. / Spieldenner, J. et al. | 2011
-
PSS39 Assessment of the Health Status Using the 12-Item Medical Outcomes Study Short Form (SF-12) Questionnaire (2578 Dermatological Out-Patients)Tabolli, S. / Pagliarello, C. / Paradisi, A. / Spagnoli, A. / Sampogna, F. / Abeni, D. et al. | 2011
-
EX4 Efectividad De Los indicadores De Calidad De La Prescripción Regionales En El Sns EspañolGarrido, E. / Sabater, F. J. / Hurtado, P. / Espinó / s, B. / Guarga, L. / Garcí / a Losa, M. / Vieta, A. / Badia, X. et al. | 2011
-
QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in MéxicoOliva-Oropeza, P. / Quiroz Angulo, M. E. / Marco Antonio, A. C. et al. | 2011
-
HS1 Interchangeability Between Pneumococcal Conjugate Vaccines and SchemesCiapponi, A. / Garcí / a Martí / S. / Rey-Ares, L. / Glujovsky, D. / Bardach, A. / Valanzasca, P. / Lee, A. / Cafferata, M. L. et al. | 2011
-
PCN5 Efectividad CLÍnica Y Costo-Efectividad Del Tratamiento De Segunda LÍnea Para Carcinoma MetastÁsico De CÉlulas RenalesRomero, M. / Dí / az, E. / Malagon, J. et al. | 2011
-
PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System PerspectiveSchiola, A. / Silva, A. P. / Santoni, N. B. / Paladini, L. / Teich, V. / Pepe, C. / Rocha, M. M. et al. | 2011
-
PDB3 Prevalence of Severe Osteoporosis in Daily Consultation of Rheumatology and Endocrinology Services, Costs and Quality of Life of Fragility Fractures in MexicoCarlos, F. / Clark, P. / Chico, G. / Ramí / rez, E. / Franco, F. / Jasqui-Romano, S. et al. | 2011
-
PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in MexicoMayen-Herrera, E. / Pozos, J. C. / Yang, M. / Cortina, D. et al. | 2011
-
PHP28 Decentralisation of Health Services Planning and Management: The Varying Perspectives of Health Workers and Community Members at Nanumba North District, GhanaAgyei-Baffour, P. / Atta, K. / Nakua, E. / Owusu-Dabo, E. et al. | 2011
-
PHP32 Lineamientos De Una PolÍtica De investigación En Salud En Chile: Acuerdos De La Comisión Técnica De investigación Sanitaria Para El Plan Nacional De Salud 2011-2020Espinoza, M. A. / Cabieses, B. / Zitko, P. / Castillo, C. / Castillo, M. / Jeria, M. M. / Valenzuela, M. T. / Delgado, M. / Ramirez, J. et al. | 2011
-
PHP35 Perceptions, Knowledge and Gaps about HTA and Health Economics by the Braziian Market Stakeholders: Ispor Brazil Qualitative ResearchAraú / jo, G. T. / Fonseca, M. / Stefani, S. D. et al. | 2011
-
PHP49 Developing Risk Sharing Arrangements – Potential for Brazil and ImplicationsShirk, R. C. / Godman, B. et al. | 2011
-
PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin AmericaSzabo, S. M. / Donato, B. M. / Yuan, Y. / Bibby, M. / Jimenez-Mendez, R. / Levy, A. R. et al. | 2011
-
PIN7 COST-Effectiveness Analysis Of Anti-Pneumococcal Vaccines Versus No Vaccination In El SalvadorDueñ / as, M. D. / Lutz, M. / Morales, G. / Strutton, D. R. / Roberts, C. / Cuesta, G. / Farkouh, R. A. et al. | 2011
-
PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At IsssteRamí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. et al. | 2011
-
PMS6 Health Care resource Utilization of Thai Hip Fracture Patients in Public Hospital: Cost of Illness analysis at Chiangrai HospitalSrisawi, K. / Thepnamwong, J. / Sukwong, D. P. / Reungjarearnrung, K. et al. | 2011
-
PRS7 Estudio De Costo-Efectividad De Beclometasona vs Ciclesonida Como Medicamentos Controladores En El Manejo Del asma En Pacientes Que asisten A Consulta Externa De NeumologÍa Pediátrica En El Hospital Universitario Clínica San Rafael De BogotÁ Colombia, Julio A Diciembre 2010Hinestrosa, F. / Pedraza, A. M. et al. | 2011
-
PSS2 Encouraging The Efficiency Of The National Transplant PROGRAM: Estimating The Cost Of Corneal Transplant To Be Financed By Public Institutions In The Health Sector In MEXICOCamacho, A. / Gutierrez, C. et al. | 2011
-
NI2 The Impact of Nice Guidance on the Diffusion of Medical DevicesCabo, R. / Sorenson, C. / Lynch, P. / Eggington, S. et al. | 2011
-
RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For MedicinesPuig-Peiró / R. / Mestre-Ferrandiz, J. / Sussex, J. / Towse, A. et al. | 2011
-
PMD1 Nd-Yag Laser Incidence Rate Comparison of Three Monofocal Intraocular Lenses (IOL) 36 Months after Cataract Surgery in FranceLafuma, A. / Coulomb, S. / Robert, J. / Berdeaux, G. et al. | 2011
-
PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients: Systematic ReviewSilva, A. P. / Santoni, N. B. / Pepe, C. / Laranjeira, F. et al. | 2011
-
PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and BelgiumArvandi, M. / Bornschein, B. / Gothe, R. M. / Rioufol, G. / De bruyne, B. / De pouvourville, G. / Desmet, W. / Lefevre, T. / Fearon, W. F. / Pijls, N. H. et al. | 2011
-
PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in SpainBusutil, R. / Ferko, N. / Espallardo, O. / Saadi, R. et al. | 2011
-
PMD58 Provision and Financing of Medical Aids in the Management of Rare Diseases: The Case of Amyotrophic Lateral Sclerosis (ALS)Henschke, C. et al. | 2011
-
PMD76 Are Health Technology Assessments of Medical Devices Catching up with Pharmaceuticals?Sweeney, N. / Andreykiv, M. / Wiebinga, C. et al. | 2011
-
PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands: How Much Practice Variation is There?Buisman, L. / Silitonga, A. / Rijnsburger, A. / Redekop, W. et al. | 2011
-
PSU6 Long Term Effectiveness of Limbal Relaxing Incision (LRI) During Cataract Surgery to Correct AstigmatismGauthier, L. / Lafuma, A. / Robert, J. / Kunisk-Joinville, O. / Berdeaux, G. et al. | 2011
-
PSU25 Effectiveness of Minimally Invasive Surgery for Total Hip ArthroplastyNavarro Espigares, J. L. / Hernandez Torres, E. / Ruiz Arranz, J. L. / Padial Ortiz, M. A. / Aranda Villalobos, P. et al. | 2011
-
PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment ComparisonWojciechowski, P. / Stozek, A. / Szmyd, J. / Gwiosda, B. / Mierzejewski, P. / Kazmierski, M. / Rys, P. / Wladysiuk, M. / Plisko, R. et al. | 2011
-
PIN9 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C TreatmentAggarwal, S. et al. | 2011
-
PIN29 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus: A Cost Comparison Analysis Under the Private Payer Perspective in BrazilFujii, R. K. / Takemoto, M. L. / Mould, J. F. / Lanzara, G. / Fernandes, R. A. / Santos, P. M. / Takemoto, M. M. et al. | 2011
-
PIN28 Consumption Pattern and the Cost Analysis of Parenteral Antibiotics in AHettihewa, L. M. / Subasinghe, S. / Nilakshi, K. / Cooray, P. et al. | 2011
-
PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United StatesGao, X. / Ji, X. / Stephens, J. M. / Schlamm, H. / Tarallo, M. et al. | 2011
-
PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care PlanJoish, V. N. / Boklage, S. F. / Luong, B. / Operschall, E. / Spilsbury-Cantalupo, M. et al. | 2011
-
PIN59 A Cost-Effectiveness Analysis of Voriconazol, Anfotericine B and Caspofungin for Invasive Aspergilosis Patients in PanamaLutz, M. A. / Trujillo, J. M. / Morales, G. / Cuesta, G. et al. | 2011
-
PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in PakistanHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
-
PMH14 Speed of Detection of Adverse Events in Spontaneous Adverse Event Databases Compared with Epidemiological Studies: Two related CasesQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
-
PMH19 Cost of Relapse in Schizophrenia in Europe: The Constatre StudyHemels, M. / Diels, J. / Gonzá / lez, B. / Jensen, R. et al. | 2011
-
PMH74 Impact of Age and Gender in the Pharmaceutical Expenditure of Anxiolytics in Primary Health CareGuadalajara-Olmeda, N. / De la Poza-Plaza, E. / Barrachina-Martí / nez, I. / Vivas-Consuelo, D. et al. | 2011
-
PMH79 The Impact of Comparative Effectiveness Research on Health and Health Care SpendingBasu, A. / Jena, A. B. / Philipson, T. J. et al. | 2011
-
PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis PatientsLeReun, C. / Neophytou, I. / De Vries, R. / Diamantopoulos, A. / Pompen, M. et al. | 2011
-
PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care PopulationKozma, C. M. / Bhattacharyya, S. K. / Palazola, P. et al. | 2011
-
PMS54 The Clinical and Economic Burden of Poor Adherence with Osteoporosis Medications in IrelandHiligsmann, M. / Mcgowan, B. / Bennett, K. / Barry, M. / Reginster, J. Y. et al. | 2011
-
PND24 Cost of Symptomatic Drug Therapy in Multiple SclerosisFogarty, E. / Tilson, L. / Barry, M. et al. | 2011
-
PUK16 Known-Group Validity of the Spanish Version of the Short-Form Overactive Bladder Health Related Quality of Life Questionnaire (OABQ-SF) in Subjects with Overactive BladderArlandis-Guzmá / n, S. / Ruiz, M. A. / Errando-Smet, C. / Villacampa-Aubá / F. / Arumi, D. / Lizarraga, I. / Ruiz, L. / Rejas, J. et al. | 2011
-
PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?Vogler, S. / Zimmermann, N. / Leopold, C. / Habl, C. / Mazag, J. et al. | 2011
-
PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?Usher, C. / Bennett, K. / Barry, M. et al. | 2011
-
PHP51 Pill Burden in South African Patients With Multiple Risk Factors for Metabolic SyndromeBurger, J. R. / Lubbe, M. S. / Serfontein, J. H. et al. | 2011
-
PHP78 Convergent Tendencies in Budget Impact Analysis Across Europe and Beyond: Germany - Don'T Lose out on the “Zeitgeist”!Bechtel, B. / Welte, R. et al. | 2011
-
PHP89 Detection of Medication Errors in the Thai FDA Database of Adverse Drug Reactions ReportsBunchuailua, W. / Bunthum, K. / Poonpanich, N. / Limpreedeechai, P. / Angkasirikumjorn, A. / Suwankesawong, W. et al. | 2011
-
PHP139 Evolving P&R Complexities are Affecting Launch Sequencing and Time to Market in 18 Developed and Emerging MarketsMarinoni, G. / Bharath, A. / Gennero, R. / Honoré / A. C. / Melck, B. / Rodrigues, T. / Uki-Eagleton, A. / Izmirlieva, M. A. / Calnan, G. et al. | 2011
-
PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR DelegatesKyral, A. / Johnson, K. I. et al. | 2011
-
PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South KoreaKim, E. S. / Lee, B. J. / Lee, E. K. et al. | 2011
-
PHP161 Towards an Efficient National Drug Policy in the Russian FederationRudisill, C. / Antoun, J. / Vandoros, S. et al. | 2011
-
PHP166 On-Going Market Access Advice A Possible solution to Help Ensure Long-Term Success in Post-Marketing Clinical Studies: Cross Functional Teams or External Consultation?Kirpekar, S. / Mallinson, M. et al. | 2011
-
PHP167 Tell Me Who Your Friends are: “Peers” in Comparing Health Care SystemsCarrera, P. et al. | 2011
-
PCV1 Explorative Analysis about the Appropriateness of a GPS Longitudinal Database on Evaluating Atypical Antipsychotics in Terms of Drugs Adverse EventsHeiman, F. / Pegoraro, V. / Katz, P. / Didoni, G. / Calandriello, M. et al. | 2011
-
PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practice: Data from the Multinational, Prospective, Antiplatelet Treatment Outcomes Registry (APTOR)James, S. / Iniguez, A. / Pavlides, G. / Zeymer, U. / Sartral, M. / Belger, M. / Tomlin, M. E. / Norrbacka, K. / Bakhai, A. et al. | 2011
-
PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in AustraliaBadcock, C. A. / Lee, J. / Gonzalo, F. et al. | 2011
-
PCV30 Heart Failure (Re)Admissions in the Netherlands: Rates, Length of Stay and CostsOverbeek, J. A. / Penning-van Beest, F. J. / Herings, R. M. / Agodoa, I. et al. | 2011
-
PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the NetherlandsOverbeek, J. A. / Penning-Van Beest, F. J. / Herings, R. M. / Agodoa, I. et al. | 2011
-
PCV74 Is Treatment of Depression Cost Effective in the Management of People with CHD and Diabetes: A Systematic Review of the Economic EvidenceJeeva, F. / Davies, L. M. et al. | 2011
-
PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community PharmaciesOosterhof, P. / Van Boven, J. F. / Visser, S. T. / Hiddink, E. G. / Stuurman-bieze, A. G. / Postma, M. J. / Vegter, S. et al. | 2011
-
PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS): A Dutch Analysis Based on the Plato TrialThurston, S. / Heeg, B. / Hofsté / C. et al. | 2011
-
PCV111 Economic Burden and Health- Related Quality of Life in European Patients with Peripheral Arterial DiseaseMarrett, E. / Dibonaventura, M. D. / Zhang, Q. et al. | 2011
-
PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care PatientsMclernon, D. J. / Dillon, J. F. / Donnan, P. T. et al. | 2011
-
PGI11 Cost Analysis of Antihelicobacter Therapy of Gastric and Duodenum Ulcer in UkraineGerasymova, O. / Iakovlieva, L. / Tkacheva, O. et al. | 2011
-
PGI31 The Maintenance of Work-related Productivity During One Year of MMX Mesalamine Treatment for Patients with Quiescent Ulcerative ColitisYen, L. / Yarlas, A. / Hodgkins, P. / Solomon, D. / Karlstadt, R. / Kane, S. V. et al. | 2011
-
PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insuranceChoi, S. E. / Lim, E. A. / Park, J. H. / Lee, M. K. / Jung, S. W. / Cho, H. Y. et al. | 2011
-
PIH38 Self Reported Health Status and Quality of Life Among Coastal Rural Population in South IndiaMuragundi, P. M. / Udupa, N. / Naik, A. N. / Tumkur, A. / Shetty, R. et al. | 2011
-
PIH64 Female Urinary Incontinence in Germany– Cost Explosion Tomorrow?Zakrzewska, K. / Henkel, I. et al. | 2011
-
PIH52 Medicine Prescribing Patterns in HIV/AIDS and Non-HIV/AIDS Children: A Comparitive Study in the Private Health Care Sector of South AfricaMocke, M. / Lubbe, M. S. / Burger, J. R. et al. | 2011
-
PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?Vickers, D. M. / Anonychuk, A. / De Wals, P. / Bauch, C. T. et al. | 2011
-
PSY26 Cost Benefit Analysis of a Worksite Weight Management ProgramIdris, A. / Fernandez, I. D. / Fiscella, K. A. / Noyes, K. et al. | 2011
-
PRM2 The Reporting of Observational Studies in Spain: Analysis Using the Strobe StatementGalera, J. / Lahoz, R. / Roig, F. et al. | 2011
-
PRM29 Translation and Validation Study of Morisky Medication Adherence Scale (MMAS): The Urdu VersionSaleem, F. / Hassali, M. A. / Shafie, A. A. / Al-Qazaz, H. K. / Atif, M. / Haq, N. / Ahmad, N. / Asif, M. et al. | 2011
-
PRM34 Examining Variations in Item Structure and Content in Pro Instruments, or, There Must be 50 Ways to Express Your DistressErickson, P. / Willke, R. J. et al. | 2011
-
PRM47 Review of Clinician and Observer Reported Outcomes Measures Translation MethodologiesZarzar, K. M. et al. | 2011
-
PRM69 Measuring Relative Effectiveness in Europe: As in the USA, Here Too, It is Time to Turn the QALY PagePrieto, L. et al. | 2011
-
PCN30 Comparative Analysis of Cost and Resource Use Among Patients With Brain Metastasis by Initial Primary CancerGanguli, A. / Dacosta Byfield, S. / Teitelbaum, A. / Ray, S. et al. | 2011
-
PCN35 Capecitabine for the Treatment of Colorectal Cancer in Private Health System in Brazil: A Budgetary Impact Analysis Based on Real World DataClark, O. / Clark, L. G. / Botrel, T. E. / Paladini, L. / Medina, P. / Rosa, B. / Fiol, E. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
-
PCN49 Incidence Rate and Burden of Illness Associated with Human Papillomavirus Related Genital Cancers in Spanish WomenRana, C. / Mann, K. / Wadhwa, A. / Pathak, P. et al. | 2011
-
PCN54 Hospital Costs Related to Hepatitis C Virus Infection: First Analysis of the French Hospital National Data BaseRotily, M. / Vainchtock, A. / Lannuzel, X. / Jouaneton, B. / Wartelle-bladou, C. / Anceau, A. et al. | 2011
-
PCN56 Are Out-of-Pocket Payments for Oral Oncologic Therapies Too High? Updated Results From A U.S. Claims Data AnalysisRaborn, M. L. / Pelletier, E. M. / Smith, D. B. / Reyes, C. M. et al. | 2011
-
PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC): Economic Modeling (EM) resultsSantos, E. A. / Buschinelli, C. T. / Ferracini, M. / Pepe, C. / Estanislao, M. et al. | 2011
-
PCN84 Population Vaccination Program for Human Papillomavirus in Spanish Girls: An Efficiency StudyLorente, M. R. / Antonanzas, F. et al. | 2011
-
PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian SettingCurescu, S. / Stanculeanu, D. L. / Croitoru, A. / Radu, C. P. et al. | 2011
-
PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the NetherlandsLothgren, M. / Bracco, A. / Lucius, B. / Northridge, K. / Halperin, M. / Macarios, D. / Chung, K. / Danese, M. D. et al. | 2011
-
PCN123 A Literature Review on Utility Values Associated With HPV-Related DiseasesShupo, F. / Dorey, J. / Remy, V. / Aballea, S. et al. | 2011
-
PCN142 Methodological Limitations of Patient-Reported Outcome Measures (PROMs) in oncology: A Meta-ReviewSmith, A. B. / Taylor, M. / Parry, D. et al. | 2011
-
PCN145 Measurement Properties of the English and Chinese Versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer PatientsNg, R. / Lee, C. F. / Wong, N. S. / Luo, N. / Yap, Y. S. / Lo, S. K. / Chia, J. / Yee, A. / Krishna, L. / Goh, C. et al. | 2011
-
PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer PatientsGamper, E. M. / Giesinger, J. M. / Oberguggenberger, A. / Wintner, L. / Singer, S. / Buxbaum, S. / Waitz, D. / Putzer, D. / Nilica, B. / Virgolini, I. et al. | 2011
-
PCN166 Public Accountability and Social Judgment in the Reimbursement Decision for Oncology Medications in KoreaCho, E. / Kang, M. et al. | 2011
-
PCN173 Cancer Incidence Evaluation and Pathway Identification for Treatment Course Detection Using Billing Data for AustriaZauner, G. / Einzinger, P. / Endel, G. / Breitenecker, F. et al. | 2011
-
PCN197 Health Related Quality of Life in Long Term Survivors of Lymphoma: A Population Based StudyBlommestein, H. / Versteegh, M. / Oerlemans, S. / Van de Poll-Franse, L. / Uyl-de Groot, C. et al. | 2011
-
PDB10 Achieving Target Goals in Patients with T2DM Treated with Exenatide Once Weekly or Insulin Glargine: A Retrospective Analysis of the Number-Needed-To-TreatBruhn, D. / Han, J. / Meloni, A. / DeYoung, M. B. / Anderson, P. W. et al. | 2011
-
PDB27 Projected Cost-Effectiveness of Exenatide Once Weekly Versus Exenatide Bid for the Treatment of Type 2 Diabetes in the UKWilson, B. P. / Beaudet, A. / Caputo, J. / Timlin, L. et al. | 2011
-
PDB33 Cost of Diabetes Management to Cocoa Clinics in GhanaQuaye, E. A. / Akweongo, P. / Aikins, M. K. et al. | 2011
-
PDB41 The Cost-Effectiveness of Getting to Glucose, Blood Pressure, and Lipid Goals in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in SwedenHe, J. / Neslusan, C. / Willis, M. / Worbes-Cerezo, M. et al. | 2011
-
PDB51 A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir Flexpen® or NPH Insulin in a VialBuysman, E. / Aagren, M. / Liu, F. / Bouchard, J. / Conner, C. et al. | 2011
-
PDB75 Analysis of the Medicines Pricing Procedure in the Republic of MacedoniaAngelovska, B. / Ivanovska, V. / Manova, M. / Petrova, G. et al. | 2011
-
PDB76 Knowledge, Medication Adherence and Glycemic Control Among Patients with Type 2 Diabetes MellitusAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
-
PRS13 Specific Immunotherapy and the Economic Implications from the Perspective of German Statutory Health Insurance - a Budget-Impact Modeling ApproachReinhold, T. / Willich, S. N. / Brü / ggenjü / rgen, B. H. et al. | 2011
-
PRS18 Economic Burden of Cystic Fibrosis in the US: Costs of Care By Disease Severity and AgeBecker, C. C. / Clements, K. / DeLong, K. / Harrow, B. / O' / Sullivan, A. et al. | 2011
-
PRS42 Pharmacoeconomic Analysis of Methylprednisolone Aceponate for Treatment of Atopic Dermatitis and EczemaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Margieva, A. / Hajlov, P. / Korsunskaja, I. et al. | 2011
-
PRS45 Fully Incremental Cost-Effectiveness Analysis of Available Treatment Options in the Management of Severe COPD in the UK SettingKotchie, R. / Samyshkin, Y. / Hertel, N. / Radford, M. / Jameson, K. / Humphreys, S. et al. | 2011
-
PRS52 Inpatient Hospital Care or Hospital-At-Home for COPD Exacerbations: A Discrete Choice ExperimentGoossens, L. / Rutten-Van Mö / lken, M. et al. | 2011
-
PRS58 Treatment Outcomes of New Smear Positive Pulmonary Tuberculosis Patients in North East LibyaSolliman, M. M. / Hassali, M. A. / Shafie, A. A. / Atif, M. / Saleem, F. / Al-Haddad, M. S. / Hadidan, M. et al. | 2011
-
PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of TherapyOskina, E. et al. | 2011
-
PRS71 Evaluation of the Getquit Clinics for Smoking CessationPokras, S. M. / Ferrufino, C. P. / Galaznik, A. / Zou, K. / Chapman, R. et al. | 2011
-
PRS75 Health Technology Appraisal of New Drugs: Are we Getting it Right?Gordon, J. / Karnon, J. et al. | 2011
-
PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein OcclusionAlmond, C. / Hayward, E. / Freemantle, N. / Brereton, N. J. et al. | 2011
-
PSS28 Economic Burden of Advanced Melanoma: Findings From A Large US Health Insurance DatabaseOster, G. / Taneja, C. / Penrod, J. R. / Yang, A. S. / Edelsberg, J. et al. | 2011
-
PSS36 Demonstrating Conceptual Equivalence: Translation of the Cu-Q2Ol From Italian into EnglishArnold, B. J. / Baiardini, I. / Parks-Vernizzi, E. / Zazzali, J. L. et al. | 2011
-
QA1 Measuring the Benefits of Health Care: Dalys and Qalys – Does the Choice of Measure Matter? A Case StudyColantonio, L. / Augustovski, F. / Galante, J. / Bardach, A. / Caporale, J. / Zarate, V. / Chuang, L. H. / Kind, P. et al. | 2011
-
CN1 Cost-Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer in Six Latin American CountriesPichon-Riviere, A. / Augustovski, F. / Garay, O. U. / Buendia, J. / Rodrí / guez, A. / Vallejos, C. / Huayanay, L. / Oliveira, C. et al. | 2011
-
PR3 Primary Health Care Evaluation in Chile: Patients’ PerspectiveLeisewitz, T. / Nogueira, L. / Peñ / aloza, B. / Bastí / as, G. / Villarroel, L. et al. | 2011
-
RM4 Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con CineangiocoronariografÍas Realizadas En Uruguay, Financiadas Por El Fondo Nacional De RecursosMorales, M. / Perna, A. / Ferná / ndez, G. / Lombide, I. et al. | 2011
-
PCN10 Analisis De Minimizacion De Costos Entre El Uso De Iopromide Mediante Un Sistema De Aplicacion En Cascada (SIAC) Frente Al Uso De Otros Medios De Contraste Convencionales En Radiologia Invasiva En ColombiaRomero, M. / Karpf, E. / Oyuela, M. et al. | 2011
-
PCV2 Estimated Cost of Acute Coronary Syndrome for 2011: Case of MexicoRamirez, M. A. / Sanchez, A. / Piha, T. / Polanco, A. C. / Hernandez, R. / De los Rios, M. et al. | 2011
-
PDB11 Economic Evaluation of Teripatide in the Management of Women with Postmenopausal Osteoporosis and High Risk of Fragility Fractures in MexicoCarlos, F. / Clark, P. / Jasqui-Romano, S. et al. | 2011
-
PHP2 Describing Trends and Determinants of Non-Opioid Analgesic (NOA) Prescribing in Chronic Non-Cancer Pain Patients in the United States Outpatient SettingsRasu, R. / Fikru, B. / Vouthy, K. K. / Rianon, N. / Agbor Bawa, W. / Knell, M. et al. | 2011
-
PHP26 A SatisfaÇÃo Dos Profissionais De SaÚde vs A SatisfaÇÃo Dos Utentes Em Unidades De Cuidados ContinuadosAnjos, T. / Almeida, A. et al. | 2011
-
PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, GhanaAgyei-Baffour, P. / Boateng, K. / Nakua, E. / Otupiri, E. / Owusu-Dabo, E. et al. | 2011
-
PHP39 Gauging the Role of HTA in Reimbursement Decision-Making Across Five Markets in Latin AmericaDummett, H. / Kirpekar, S. / Shankland, B. et al. | 2011
-
PHP43 Exploring Social Determinants of the Health of International Immigrants in Chile: The Global Health Status IndexCabieses, B. / Tunstall, H. / Pickett, K. / Gutacker, N. / Espinoza, M. et al. | 2011
-
PIN4 Economic Impact Of Community Acquired Pneumonia Hospitalizations In Adults In Six Countries In Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
-
PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxicoReyes-Lopez, A. / Querol, J. et al. | 2011
-
PMS4 Economic Evaluation of Post-Operation orthopedic Surgery of antacid, antihemetic and analgesic Medication after Ketoprophene, Ketorolac, Parecoxib and Tenoxicam in Brazilian PatientsFujii, R. K. / Mould-Quevedo, J. F. et al. | 2011
-
PMS7 Direct Treatment-Cost of Patients with Rheumatoid Arthritis in Medellin, ColombiaMontoya, N. / Gó / mez, L. / Vé / lez, M. / Rosselli, D. et al. | 2011
-
PND4 El Impacto Economico Del Tabaquismo En El Desarrollo De La Enfermedad Vascular Cerebral En Un Centro Neurologico De Tercer NivelSan-Juan, D. / Quintana Carrillo, R. / Arauz Gó / ngora, A. / Ló / pez de Santiago, I. / Aguire-Cruz, L. / Corona, T. / Reynales Shigematsu, L. et al. | 2011
-
PSS3 Un Estudio De Costo-Efectividad Para Evaluar El Tratamiento Con N-Acetil Cisteína En Pacientes Con Esclerosis SistémicaLopez, J. A. / Briones, B. et al. | 2011
-
PSY4 Modelo De Costo Beneficio De Lidocaina En Parche Al 5% Versus Pregabalina 300 Mg Y 600 Mg Al Día Para El Tratamiento De La Neuralgia PostherpéticaRojas, L. A. / Martinez, J. A. et al. | 2011
-
PSY12 Laparoscopy Versus Open Roux-en-y Gastric Bypass For Morbid Obesity: Cost-Utility AnalysisSilva, E. N. / Silva, M. T. / Elias, F. T. / Laranjeira, F. O. / Mottin, C. C. et al. | 2011
-
PUK3 COST-Effectiveness Of Anemia Treatment In Dialysis Patients In BRAZILSilva, F. H. / Vianna, C. M. / Silva, F. V. et al. | 2011
-
MO1 Methods for Extrapolating Survival Data Used in NICE Technology Appraisals: Inconsistencies and LimitationsLatimer, N. et al. | 2011
-
PMD12 Economic Impact analysis of Sterilization of Rigid Endoscopes with Sterradtm versus Steam in SpainBusutil, R. / Espallardo, O. / Emmermann, A. et al. | 2011
-
PMD48 An Economic Evaluation of the Heartware Ventricular assist Device in the NHSCraig, J. / Saxby, R. C. / Homer, T. / Swartz, M. T. et al. | 2011
-
PMD51 Cost Savings and Improved Utility through the Use of Florbetaben Beta-Amyloid PET Imaging in Dementia DiagnosisPastä / tter, R. / Uhl-hochgrä / ber, K. / Blankenburg, M. et al. | 2011
-
PMD72 Mamma Carcinoma – Data analyses and Classification of Treatment in AustriaSchiller-frü / hwirth, I. / Zauner, G. / Einzinger, P. / Breitenecker, F. et al. | 2011
-
PMD78 Benefit-Risk Analysis in Absence of Clinical Evidence: Deciding for Treatment of Skull Deformity in Babies Aged 5 MonthsVan Til, J. A. / van der Maas, E. W. / Boere-Boonekamp, M. M. / Van Vlimmeren, L. / Ijzerman, M. J. et al. | 2011
-
PSU1 Suprapubic Tube Placement Related Bowel Injury: Proposed Guidelines for Open PlacementEllsworth, P. / Tompkins, A. / Lasser, M. et al. | 2011
-
PIN10 Clinical and Economic Burden of Hospital Onset Health Care Facility Acquired Clostridium Difficile Infection (HO-HCFA-CDI) in Europe: A Systematic ReviewWiegand, P. / Nathwani, D. / Wilcox, M. / Stephens, J. M. / Wan, W. / Shelbaya, A. / Haider, S. et al. | 2011
-
PIN11 The Impact of Directly Observed Therapy (DOT) in Patients with TuberculosisSallum, R. H. / Travers, K. U. / Kalsekar, A. / Kleinman, L. et al. | 2011
-
PHP142 Landmark CER Study Methods ReviewCummins, G. / Britton, K. / Doyle, J. et al. | 2011
-
PIN27 Cost analysis of the Consumed Oral Antibiotics in a Tertiary CareSubasinghe, S. / Hettihewa, L. / Cooray, P. / Kulathunga, N. et al. | 2011
-
PIN37 The Cost of Managing Chronic Hepatitis C in Sweden - Medical Resource Utilisation in Different Stages of the DiseaseOrrskog, S. / Friberg, S. / Lenre, M. / Bä / ckman, L. / Duberg, A. S. / Flamholc, L. / Friman, S. / Hollander, A. / Sangfelt, P. et al. | 2011
-
PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS ProgramMorais, A. D. / Pereira, M. L. / Azevedo, H. et al. | 2011
-
PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) TreatmentGwiosda, B. / Krzystek, J. / Niesyczynski, G. / Osiewalski, K. / Mierzejewski, P. / Kazmierski, M. / Wladysiuk, M. / Plisko, R. et al. | 2011
-
PIN82 Cost-Effectiveness of Atazanavir/R Compared to Darunavir/R in GermanyThuresson, P. O. / Verheggen, B. / Heeg, B. / Kaspar, I. / Erhardt, W. / Lescrauwaet, B. et al. | 2011
-
PIN88 Late Immunization Doses Received by Children Younger than Two YearsAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Saleh, M. R. / Basher, A. Y. / Shafie, A. A. et al. | 2011
-
PGI21 Cost-Effectiveness of Peginterferon and Ribavirin for Elderly Patients with Chronic Hepatitis C: Results Based on the Nationwide Hepatitis Registration in JapanShimbo, T. / Nagata-Kobayashi, S. / Masaki, N. et al. | 2011
-
PIH35 The Measurement and Valuation of Health Status Using EQ-5D in Brazil: A Systematic reviewTakemoto, M. L. / Fernandes, R. A. / Cukier, F. N. / Cruz, R. B. / Takemoto, M. M. / Santos, P. M. / Tolentino, A. C. / Ribeiro, A. C. / Fernandes, R. R. / Moretti, A. I. et al. | 2011
-
PIH47 Measuring the Burden of Disease and Injury in Spain Using Disability-Adjusted Life Years: A Population-Based StudyGè / nova-Maleras, R. / lvarez-Martí / n, E. / Morant-Ginestar, C. / Ferná / ndez de Larrea, N. / Catalá / pez, F. et al. | 2011
-
PIH51 What Do Patients with Rare Diseases Experience in the Medical Encounter? Exploring Patient-Physician-Interaction Patterns, Its Antecedents and Its ConsequencesBudych, K. / Helms, T. M. / Schultz, C. et al. | 2011
-
PIH59 Are Older Mothers More prone to Having Children with Disabilities? Lifetime Disability Outcomes Versus Multiple Birth Reductions Arising from In-Vitro Fertilization (IVF) Treatments in CanadaZowall, H. / Brewer, C. et al. | 2011
-
PSY3 The Potential Impact of Obesity Degree on Diabetes, Heart Attack, Hypertension, Chronic Anxiety and Depression in Adult Spanish PopulationEspallardo, O. / Busutil, R. / Ribaric, G. / Lopez-belmonte, M. et al. | 2011
-
PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish MarketDarba, J. / Kaskens, L. / Perez-Alvarez, N. et al. | 2011
-
PSY6 The Health Improvement Network (Thin) 2008-2009 Estimates of Psoriasis Incidence and Prevalence in Uk Primary CareKhalid, J. M. / Globe, G. / Fox, K. M. / Chau, D. / Maguire, A. et al. | 2011
-
PSY37 Assessment of the Global Cost of Transfusion in French Orthopedic Surgery WardsDos-Reis, J. / Bernard, M. / Beucher, S. / Catonné / Y. / Massin, P. / Sautet, A. / Tilleul, P. et al. | 2011
-
PSY39 Predictors of Health Utilities Among Patients with Rheumatoid Arthritis in EuropeDibonaventura, M. D. / Pisa, G. / Schwankl, M. et al. | 2011
-
PSY44 Association of the Obesity and Weight-Loss Quality-of-Life Score With Patient Demographics and Measures of ObesityLee, L. J. / Nelson, D. R. / Curtis, B. / Gaich, G. A. et al. | 2011
-
PSY51 Epidemiology and Treatment Patterns of inhibitor Hemophilia in Russia: Patient-reported DataVorobyev, P. A. / Krasnova, L. / Borisenko, O. / Zhulyov, Y. / Bezmelnitsyna, L. et al. | 2011
-
PSY55 Cost of Autologous and Allogeneic Stem Cell Transplantations for Haematological Disease: A Dutch Multicentre Daily Practice StudyBlommestein, H. / Verelst, S. / Cornelissen, J. / Huijgens, P. / Blijlevens, N. / Uyl-de Groot, C. et al. | 2011
-
PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in SpainOlveira, A. / Rincon, D. / Diago, M. / Crespo, J. / Calleja, J. L. / Salmeron, J. / Andrade, R. / Romero, M. et al. | 2011
-
PIN108 Sustained Virological Response as Patient-Relevant Endpoint in Hepatitis C?Kossmann, B. / Neuhä / user, M. / Schauer, S. / Slawik, L. / Fleischmann, J. / Wasem, J. / Aidelsburger, P. et al. | 2011
-
PRM14 Mondriaan: A Dutch 'Population' LaboratoryKlungel, O. et al. | 2011
-
PMH15 Mortality in relation to Disease Severity in Subjects with DementiaJonsson, L. / Fratiglioni, L. / Wimo, A. et al. | 2011
-
PMH24 Economic Burden of Mental Illnesses in PakistanMalik, A. M. / Khan, M. M. / Khan, Z. M. et al. | 2011
-
PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone – A Markov Model Parameterized Using Administrative DataFrey, S. / Stargardt, T. / Linder, R. / Juckel, G. et al. | 2011
-
PMH37 Cost-Minimisation Analysis of Asenapine Monotherapy Versus Other Antipsychotics in Bipolar I Disorder in Two Nordic CountriesDespié / gel, N. / Davie, A. M. / Corson, H. / Beillat, M. / Sapin, C. et al. | 2011
-
PMH57 Association of Antidepressant-Related Weight Gain with Degree of Enjoyment and Satisfaction Regarding General Daily Activities, Medication and Overall Quality of LifeSchneider, G. / Roy, A. / Dabbous, O. H. et al. | 2011
-
PMH76 Patterns and Determinants of Sickness Absence Among Users of Antidepressants in a Danish Working PopulationGasse, C. / Chollet, J. / Petersen, L. / Saragoussi, D. et al. | 2011
-
PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World DataBonafede, M. / Gandra, S. R. / Watson, C. / Princic, N. / Fox, K. M. et al. | 2011
-
PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in GreeceAthanasakis, K. / Karampli, E. / Hollandezos, M. / Papagiannopoulou, V. / Badamgarav, E. / Intorcia, M. / Kyriopoulos, J. et al. | 2011
-
PMS21 Differences in Cost-of-Illness and Quality of Life Between Rheumatoid Arthritis and Ankylosing Spondylitis in South KoreaLee, T. J. / Park, B. H. / Son, H. K. / Kim, J. W. / Shin, K. / Lee, E. B. / Song, Y. W. et al. | 2011
-
PMS34 Cost-Effectiveness Analysis of Bio- Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis in MexicoAguirre, A. / Bierschwale, H. / Espinosa, F. / Michel, M. / Aguilera, J. / Esquivel, R. / Oliva, C. / Sierra, M. / Martí / nez, M. et al. | 2011
-
PMS38 A Structured Literature Review of Rheumatoid Arthritis Economic Models for Biologicsvan Nooten, F. / Gajria, K. / Kansal, A. R. et al. | 2011
-
PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the NetherlandsDiamantopoulos, A. / Kievit, W. / De Vries, R. / Pompen, M. et al. | 2011
-
PMS50 Cost-Effectiveness of Biologic Agents Compared with Methotrexate in the Treatment of Rheumatoid Arthritis in ColombiaValle-Mercado, C. / Cubides, M. F. / Parra-Torrado, M. / Rosselli, D. et al. | 2011
-
PMS57 Preliminary Psychometric Validation of the Sleep Disturbance and Sleep Adequacy Subscales of the 1-Week Recall Medical outcomes Study Sleep Scale in Patients with Rheumatoid ArthritisMeldahl, M. L. / Sterling, K. L. / Zagar, A. / Naegeli, A. et al. | 2011
-
PMS70 Evaluation of Prescribed Pain Medications Prior to the Initiation of Duloxetine Therapy in a Commercially Insured PopulationWu, N. / Peng, X. / Chen, S. Y. / Bernauer, M. / Cheung, M. / Boulanger, L. / Zhao, Y. et al. | 2011
-
PND1 Estimating Net Health Benefits Of Intramuscular Interferon Beta-1A And Fingolimod In Treating Patients With Relapsing-Remitting Multiple SclerosisSzabo, S. M. / Dembek, C. / Moore, P. / White, L. A. / Wijaya, H. / Levy, A. R. et al. | 2011
-
PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying TherapyHettle, R. / Murphy, J. / Eckert, B. et al. | 2011
-
PND16 Health Economics of Sclerosis Multiplex in SlovakiaPsenkova, M. / Paluch, A. / Bielik, J. / Novak, I. et al. | 2011
-
PND30 Cost-Effectiveness of Early vs. Non-Early Intervention in Acute Migraine with Almotriptan in SpainSlof, J. et al. | 2011
-
PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak RepublicBenhaddi, H. / Poliakova, Z. et al. | 2011
-
PND45 Development and Validation of the Multiple Sclerosis Rating Scale-Revised (MSRS-R)Wicks, P. / Vaughan, T. E. / Massagli, M. P. et al. | 2011
-
PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease: Systematic Review and Mixed Treatment ComparisonStradwick, S. / Hartmann, J. / Morgan, A. / Freemantle, N. et al. | 2011
-
PHP40 Perception Study of Undergraduates Towards Medicines – A SurveyUdupa, N. / Dharmagadda, S. / Ligade, V. / Muragundi, P. M. et al. | 2011
-
PHP53 Assessment of the Attitudes of the General Public Towards Supplementary Criteria to Be Used in P&R Decision Making Process in PolandKolasa, K. / Lees, M. et al. | 2011
-
PHP57 Centralized Drug Assessment in Catalonia: Where We Have Gone so Far?Paladio Duran, N. / Solà / Morales, O. / Sunyer Carreras-Candi, B. / Almazá / n Sá / ez, C. / Elvira, D. et al. | 2011
-
PHP65 Pharmaceutical Expenditure in Portugal – Policies and ImpactTeixeira, I. / Mendes, Z. / Ribeiro, S. / Costa, S. et al. | 2011
-
PHP112 Inter-Individual Country Variability in Monoclonal Antibodies (MABS) Reimbursement and Coverage Following EMA ApprovalRossi, C. / Miller, K. L. et al. | 2011